Infect Chemother.  2016 Mar;48(1):20-30. 10.3947/ic.2016.48.1.20.

Travel Pattern and Prescription Analysis at a Single Travel Clinic Specialized for Yellow Fever Vaccination in South Korea

• Chin BS
• Kim JY
• Gianella S
• Lee M

• KMID: 2170513
• DOI: http://doi.org/10.3947/ic.2016.48.1.20

Abstract

BACKGROUND
Travel-related risks for infectious diseases vary depending on travel patterns such as purpose, destination, and duration. In this study, we describe the patterns of travel and prescription of vaccines as well as malaria prophylaxis medication (MPM) at a travel clinic in South Korea to identify the gaps to fill for the optimization of pre-travel consultation.
MATERIALS AND METHODS
A cohort of travel clinic visitors in 2011 was constructed and early one-third of the visitors of each month were reviewed. During the study period, 10,009 visited the travel clinic and a retrospective chart review was performed for 3,332 cases for analysis of travel patterns and prescriptions.
RESULTS
People receiving yellow fever vaccine (YFV) (n = 2,933) were traveling more frequently for business and tourism and less frequently for providing non-medical service or research/education compared to the 399 people who did not receive the YFV. Overall, most people were traveling to Eastern Africa, South America, and Western Africa, while South-Eastern Asia was the most common destination for the non-YFV group. Besides YFV, the typhoid vaccine was the most commonly prescribed (54.2%), while hepatitis A presented the highest coverage (74.7%) considering the natural immunity, prior and current vaccination history. Additionally, 402 (82.5%) individuals received a prescription for MPM among the 487 individuals travelling to areas with high-risk of malaria infection. Age over 55 was independently associated with receiving MPM prescription, while purpose of providing service and travel duration over 10 days were associated with no MPM prescription, despite travelling to high-risk areas.
CONCLUSION
Eastern Africa and South America were common travel destinations among the visitors to a travel clinic for YFV, and most of them were travelling for tourism and business. For the individuals who are traveling to areas with high-risk for malaria, more proactive approach might be required in case of younger age travelers, longer duration, and travel purpose of providing service to minimize the risk of malaria infection.

Keyword

Travel medicine; Yellow fever; Vaccine; Malaria; Antibiotic prophylaxis

MeSH Terms

Africa, Eastern
Africa, Western
Antibiotic Prophylaxis
Asia
Cohort Studies
Commerce
Communicable Diseases
Hepatitis A
Immunity, Innate
Korea*
Malaria
Prescriptions*
Retrospective Studies
South America
Travel Medicine
Typhoid-Paratyphoid Vaccines
Vaccination*
Vaccines
Yellow Fever Vaccine
Yellow Fever*
Typhoid-Paratyphoid Vaccines
Vaccines
Yellow Fever Vaccine

Figure

• 

  Figure 1 Selection of eligible cases for analysis on yellow fever vaccination and other prescriptions. AT/PGU, atovaquone/proguanil; MQ, mefloquine; YFV, yellow fever vaccination; MPM, malaria prophylaxis medication.

• 

  Figure 2 Number of travelers by the visiting continents (A) Yellow fever vaccination group. (B) Non-yellow fever vaccination group. Continents with proportion of less than 1% were not visualized. YFV, yellow fever vaccination.

Reference

1. LaRocque RC, Rao SR, Lee J, Ansdell V, Yates JA, Schwartz BS, Knouse M, Cahill J, Hagmann S, Vinetz J, Connor BA, Goad JA, Oladele A, Alvarez S, Stauffer W, Walker P, Kozarsky P, Franco-Paredes C, Dismukes R, Rosen J, Hynes NA, Jacquerioz F, McLellan S, Hale D, Sofarelli T, Schoenfeld D, Marano N, Brunette G, Jentes ES, Yanni E, Sotir MJ, Ryan ET. Global TravEpiNet Consortium. Global TravEpiNet: a national consortium of clinics providing care to international travelers--analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011. Clin Infect Dis. 2012; 54:455–462.

2. Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F, Keystone JS, Pandey P, Cetron MS. GeoSentinel Surveillance Network. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006; 354:119–130.

3. van Genderen PJ, van Thiel PP, Mulder PG, Overbosch D. Dutch Schiphol Airport Study Group. Trends in knowledge, attitudes, and practices of travel risk groups toward prevention of hepatitis A: results from the Dutch Schiphol Airport survey 2002 to 2009. J Travel Med. 2012; 19:35–43.

4. Lobel HO, Baker MA, Gras FA, Stennies GM, Meerburg P, Hiemstra E, Parise M, Odero M, Waiyaki P. Use of malaria prevention measures by North American and European travelers to East Africa. J Travel Med. 2001; 8:167–172.

5. Zhang M, Liu Z, He H, Luo L, Wang S, Bu H, Zhou X. Knowledge, Attitudes, and Practices on Malaria Prevention Among Chinese International Travelers. J Travel Med. 2011; 18:173–177.

6. Wilder-Smith A, Khairullah NS, Song JH, Chen CY, Torresi J. Travel health knowledge, attitudes and practices among Australasian travelers. J Travel Med. 2004; 11:9–15.

7. Heywood A, Watkins RE, Iamsirithaworn S, Nilvarangkul K, MacIntyre CR. A cross-sectional study of pre-travel health-seeking practices among travelers departing Sydney and Bangkok airports. BMC Public Health. 2012; 12:321.

8. Yoo YJ, Bae GO, Choi JH, Shin HC, Ga H, Shin SR, Kim MS, Joo KJ, Park CH, Yoon HJ, Baek HJ. Korean travelers' knowledge, attitudes, and practices regarding the prevention of malaria: measures taken by travelers departing for India from Incheon International Airport. J Travel Med. 2007; 14:381–385.

9. Choi SH, Kim YJ, Shin JH, Yoo KH, Sung KW, Koo HH. International travel of Korean children and Dengue fever: A single institutional analysis. Korean J Pediatr. 2010; 53:701–704.

10. Kim HS, Gwack J, Yoon SK. Epidemiologic characteristics of imported malaria in Korea, 2003-2012. Public Health Wkly Rep. 2014; 7:1–7.

11. Boggild AK, Castelli F, Gautret P, Torresi J, von Sonnenburg F, Barnett ED, Greenaway CA, Lim PL, Schwartz E, Wilder-Smith A, Wilson ME. GeoSentinel Surveillance Network. Vaccine preventable diseases in returned international travelers: results from the GeoSentinel Surveillance Network. Vaccine. 2010; 28:7389–7395.

12. Sicard S, Simon F, Soula G, Gazin P. Efficacy of antimalarial chemoprophylaxis for travelers. J Travel Med. 2009; 16:66–67.

13. Kang JH, Kim HB, Sohn JW, Lee SO, Chung MH, Cheong HJ, Choi YH, Choi JH, Choi JY, Choe HJ. Adult immunization schedule recommended by the Korean Society of Infectious Diseases, 2007. Infect Chemother. 2008; 40:1–13.

14. Chung SJ, Kim TY, Kim SM, Roh M, Yu MY, Lee JH, Oh C, Lee EY, Lee S, Jeon YC, Yoo KS, Sohn JH. Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea. Clin Mol Hepatol. 2014; 20:162–167.

15. Hamada A. Past, present and future of travel medicine in Japan. Travel Med Infect Dis. 2011; 9:187–191.

16. Mizuno Y, Kudo K. Travel-related health problems in Japanese travelers. Travel Med Infect Dis. 2009; 7:296–300.

17. Ahn JY, Chung JW, Chang KJ, You MH, Chai JS, Kang YA, Kim SH, Jeoung H, Cheon D, Jeoung A, Choi ES. Clinical characteristics and etiology of travelers' diarrhea among Korean travelers visiting South-East Asia. J Korean Med Sci. 2011; 26:196–200.

18. Hung KK, Lin AK, Cheng CK, Chan EY, Graham CA. Travel health risk perceptions and preparations among travelers at Hong Kong international airport. J Travel Med. 2014; 21:288–291.

19. Lopez-Velez R, Bayas JM. Spanish travelers to high-risk areas in the tropics: airport survey of travel health knowledge, attitudes, and practices in vaccination and malaria prevention. J Travel Med. 2007; 14:297–305.

20. Angelin M, Evengård B, Palmgren H. Travel and vaccination patterns: a report from a travel medicine clinic in northern Sweden. Scand J Infect Dis. 2011; 43:714–720.

21. Pavli A, Smeti P, Spilioti A, Silvestros C, Katerelos P, Maltezou HC. Vaccinations and malaria prophylaxis for long-term travellers travelling from Greece: A prospective, questionnaire-based analysis. Travel Med Infect Dis. 2014; 12:764–770.

22. Durham MJ, Goad JA, Neinstein LS, Lou M. A comparison of pharmacist travel-health specialists' versus primary care providers' recommendations for travel-related medications, vaccinations, and patient compliance in a college health setting. J Travel Med. 2011; 18:20–25.

23. Askling HH, Rombo L, Andersson Y, Martin S, Ekdahl K. Hepatitis A risk in travelers. J Travel Med. 2009; 16:233–238.

24. Schilthuis HJ, Goossens I, Ligthelm RJ, de Vlas SJ, Varkevisser C, Richardus JH. Factors determining use of pre-travel preventive health services by West African immigrants in The Netherlands. Trop Med Int Health. 2007; 12:990–998.

25. Wieten RW, Harting J, Biemond PM, Grobusch MP, van Vugt M. Towards improved uptake of malaria chemoprophylaxis among West African travellers: identification of behavioural determinants. Malar J. 2013; 12:360.

26. Leder K, Tong S, Weld L, Kain KC, Wilder-Smith A, von Sonnenburg F, Black J, Brown GV, Torresi J. GeoSentinel Surveillance Network. Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis. 2006; 43:1185–1193.

27. Chatterjee S. Compliance of malaria chemoprophylaxis among travelers to India. J Travel Med. 1999; 6:7–11.

28. Seringe E, Thellier M, Fontanet A, Legros F, Bouchaud O, Ancelle T, Kendjo E, Houze S, Le Bras J, Danis M, Durand R. French National Reference Center for Imported Malaria Study Group. Severe imported Plasmodium falciparum malaria, France, 1996-2003. Emerg Infect Dis. 2011; 17:807–813.

29. Senn N, D'Acremont V, Landry P, Genton B. Malaria chemoprophylaxis: what do the travelers choose, and how does pretravel consultation influence their final decision. Am J Trop Med Hyg. 2007; 77:1010–1014.

30. Goodyer L, Rice L, Martin A. Choice of and adherence to prophylactic antimalarials. J Travel Med. 2011; 18:245–249.

31. Schlagenhauf P, Tschopp A, Johnson R, Nothdurft HD, Beck B, Schwartz E, Herold M, Krebs B, Veit O, Allwinn R, Steffen R. Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study. BMJ. 2003; 327:1078.